Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[The best in 2000 on arrhythmia].

J Y Le Heuzey1

  • 1Service de cardiologie, hôpital européen Georges-Pompidou, 20, rue Leblanc, 75015 Paris.

Archives Des Maladies Du Coeur Et Des Vaisseaux
|March 23, 2001
PubMed
Summary

Amiodarone effectively prevents atrial fibrillation recurrence. Automatic external defibrillators improve survival rates after sudden cardiac arrest, highlighting advancements in arrhythmia treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Editorial].

Presse medicale (Paris, France : 1983)·2016
Same author

Discontinuation And Hospitalisation Rates In Patients With Atrial Fibrillation: Follow-Up Results Of The Prefer In Af Registry.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

Antithrombotic treatment of atrial fibrillation: new insights.

Thrombosis research·2012
Same author

[The implantable defibrillator in France: from EVADEF to CeRtiTuDe].

Archives des maladies du coeur et des vaisseaux·2007
Same author

[Flecainide acetate utilisation review among general practitioners and hospital or office-based cardiologists in France. Obepine: observational study of flecainide].

Annales de cardiologie et d'angeiologie·2006
Same author

[Clinical evolution of patients following investigation of atrial vulnerability after a first cerebral ischaemic accident].

Archives des maladies du coeur et des vaisseaux·2006

Area of Science:

  • Cardiology and Electrophysiology
  • Clinical Trials and Therapeutics
  • Public Health Interventions

Context:

  • Focus on two primary rhythmology challenges: atrial fibrillation management and sudden arrhythmic death prevention.
  • Scientific literature reflects significant advancements in diagnostic and therapeutic strategies.
  • Analysis of leading clinical reviews underscores the prominence of these two conditions.

Purpose:

  • To review key therapeutic advancements in cardiology, specifically for atrial fibrillation and sudden arrhythmic death.
  • To evaluate the efficacy of amiodarone in preventing atrial fibrillation recurrence.
  • To assess the impact of automatic external defibrillation on survival rates post-ventricular fibrillation.

Summary:

  • The Canadian atrial fibrillation antiarrhythmic (CTAF) study demonstrated amiodarone's superior efficacy (35% recurrence) over Sotalol or Propafenone (63% recurrence) in preventing atrial fibrillation recurrence.
  • Two studies highlighted the effectiveness of automatic external defibrillators in confined spaces, achieving approximately 40% survival post-discharge after ventricular fibrillation.
  • Treatment paradigms are shifting towards hybrid approaches for atrial fibrillation and increased focus on preventive therapies (implantable defibrillators) for high-risk individuals.

Impact:

  • Amiodarone offers a more effective pharmacological option for managing atrial fibrillation.
  • Rapid defibrillation is crucial for improving survival outcomes in sudden cardiac arrest.
  • The trend indicates a move towards personalized and proactive strategies in managing complex cardiac arrhythmias.

Related Experiment Videos